These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 21371009)

  • 21. Treatment strategies in Alzheimer's disease with a focus on early pharmacological interventions.
    Marksteiner J; Schmidt R
    Drugs Aging; 2004; 21(7):415-26. PubMed ID: 15132710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease and frontotemporal dementia: prospects of a tailored therapy?
    Götz J; Ittner LM; Schonrock N
    Med J Aust; 2006 Oct; 185(7):381-4. PubMed ID: 17014407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease.
    Bergkvist L; Du Z; Elovsson G; Appelqvist H; Itzhaki LS; Kumita JR; Kågedal K; Brorsson AC
    FEBS Open Bio; 2020 Mar; 10(3):338-350. PubMed ID: 31823504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: towards translational challenge models for drug discovery in Alzheimer's disease.
    Babiloni C; Infarinato F; Aujard F; Bastlund JF; Bentivoglio M; Bertini G; Del Percio C; Fabene PF; Forloni G; Herrero Ezquerro MT; Noè FM; Pifferi F; Ros-Bernal F; Christensen DZ; Dix S; Richardson JC; Lamberty Y; Drinkenburg W; Rossini PM
    Clin Neurophysiol; 2013 Mar; 124(3):437-51. PubMed ID: 23040292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.
    Shepherd A; Tyebji S; Hannan AJ; Burrows EL
    J Mol Neurosci; 2016 Nov; 60(3):371-382. PubMed ID: 27637601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease.
    Altiné-Samey R; Antier D; Mavel S; Dufour-Rainfray D; Balageas AC; Beaufils E; Emond P; Foucault-Fruchard L; Chalon S
    Fundam Clin Pharmacol; 2021 Jun; 35(3):582-594. PubMed ID: 33484165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.
    Griffin EF; Caldwell KA; Caldwell GA
    ACS Chem Neurosci; 2017 Dec; 8(12):2596-2606. PubMed ID: 29022701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zebrafish as an Experimental and Preclinical Model for Alzheimer's Disease.
    Bhattarai P; Turgutalp B; Kizil C
    ACS Chem Neurosci; 2022 Oct; 13(20):2939-2941. PubMed ID: 36194560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotechnology Therapy for Alzheimer's Disease Memory Impairment Attenuation.
    Ribarič S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics.
    Paul D; Chipurupalli S; Justin A; Raja K; Mohankumar SK
    J Pharmacol Toxicol Methods; 2020; 106():106932. PubMed ID: 33091537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the gold standard model for Alzheimer's disease drug discovery and development?
    Cacabelos R; Carrera I; Martínez-Iglesias O; Cacabelos N; Naidoo V
    Expert Opin Drug Discov; 2021 Dec; 16(12):1415-1440. PubMed ID: 34330186
    [No Abstract]   [Full Text] [Related]  

  • 33. An alternative approach to drug discovery for Alzheimer's disease dementia.
    Schubert D; Maher P
    Future Med Chem; 2012 Sep; 4(13):1681-8. PubMed ID: 22924506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease.
    Veening-Griffioen DH; Ferreira GS; van Meer PJK; Boon WPC; Gispen-de Wied CC; Moors EHM; Schellekens H
    Eur J Pharmacol; 2019 Sep; 859():172524. PubMed ID: 31291566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models in the development of symptomatic and preventive drug therapies for Alzheimer's disease.
    Riekkinen P; Schmidt BH; van der Staay FJ
    Ann Med; 1998 Dec; 30(6):566-76. PubMed ID: 9920360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.
    Cummings JL; Miller BL; Christensen DD; Cherry D
    CNS Spectr; 2008 Feb; 13(2 Suppl 2):1-20; quiz 22. PubMed ID: 18264030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New and emerging treatments for Alzheimer's disease.
    Corbett A; Ballard C
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):147-56. PubMed ID: 22439621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic targets from a Drosophila model of Alzheimer's disease.
    Crowther DC; Kinghorn KJ; Page R; Lomas DA
    Curr Opin Pharmacol; 2004 Oct; 4(5):513-6. PubMed ID: 15351357
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.